Leaflet NOCLAUD 50mg tablets
Indicated for: intermittent claudication
Route of administration: oral
Substance: cilostazol (antiplatelet agent)
ATC: B01AC23 (Blood and blood forming organs | Antithrombotic agents | Platelet aggregation inhibitors excl. heparin)
This medicine may have important interactions with other medicines.
This medicine may increase the risk of bleeding.
Cilostazol is a phosphodiesterase III inhibitor used for the treatment of intermittent claudication, a condition characterized by leg pain during walking due to insufficient blood flow. It improves blood flow by dilating blood vessels and inhibiting platelet aggregation.
The medication is taken orally, usually twice daily, as directed by a doctor. It is important for patients to follow the prescribed dosage and avoid consuming grapefruit during treatment, as it may interfere with the drug's metabolism.
Patients should be aware of potential side effects, such as headaches, dizziness, or palpitations. It is important to inform the doctor of any unusual symptoms.
Common side effects include headaches, dizziness, diarrhea, and palpitations. In rare cases, severe reactions such as bleeding or allergic reactions may occur. Patients should be informed of these risks before starting treatment.
General data about NOCLAUD 50mg
- Substance: cilostazol
- Date of latest medicines list: 01-06-2020
- Product code: W60706003
- Concentration: 50mg
- Pharmaceutical form: tablets
- Quantity: 98
- Product type: Generic medicine
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Concentrations available for cilostazol
- 100mg
- 50mg